Cause for optimism on Omicron: Our immune systems aren’t blank slates
‘Dealing with naive people is never the same as even if you have some memory. It’s never like square one,’ one expert said.
‘Dealing with naive people is never the same as even if you have some memory. It’s never like square one,’ one expert said.
Sanofi’s strategy to develop new messenger RNA vaccines is adding another piece. The pharmaceutical giant struck a deal to acquire Origimm Biotechnology, a startup developing therapeutic vaccines to…
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, implementation and…
A U.S. appeals court upheld a successful challenge to a patent covering Biogen’s top-selling multiple-sclerosis treatment.
Data designer Juhan Sonin and public health professional Annie Lakey Becker explain why it’s important for people to own their health data.
Forty years after HIV infection and AIDS emerged, one child’s story illuminates what it means to be able to access the health care one needs.
Stigma continues to play a huge role in HIV’s ongoing decimation of lives in the U.S. and globally despite major scientific advancements.
The case was identified in a person with mild symptoms of Covid-19 who had traveled to South Africa and returned on Nov. 22.
‘There’s a lot of nuance to this report,’ ICER’s Steve Pearson told us. ‘Around 25% of the time we couldn’t find what we were looking for.”
The company hopes to advance the drug into a pivotal clinical study, following a mid-stage study that showed it reduced excess protein levels.